A Study to Evaluate the Safety, Tolerability, Kinetics, Biodistribution and Repeatability of 11C-BMS-986196 After Intravenous (IV) Administration in Healthy Participants and After Repeat IV Administration in Participants With Multiple Sclerosis

Clinical trial NCT05064436 · TERMINATED

Trial details

NCT number: NCT05064436
Sponsor: Bristol-Myers Squibb
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Sclerosis (MS)

Start date: 2021-12-10
Primary completion: 2023-12-18
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.